ID LMTK2_HUMAN Reviewed; 1503 AA. AC Q8IWU2; A4D272; Q75MG7; Q9UPS3; DT 31-OCT-2006, integrated into UniProtKB/Swiss-Prot. DT 17-APR-2007, sequence version 2. DT 27-MAR-2024, entry version 172. DE RecName: Full=Serine/threonine-protein kinase LMTK2; DE EC=2.7.11.1; DE AltName: Full=Apoptosis-associated tyrosine kinase 2; DE AltName: Full=Brain-enriched kinase; DE Short=hBREK; DE AltName: Full=CDK5/p35-regulated kinase; DE Short=CPRK; DE AltName: Full=Kinase/phosphatase/inhibitor 2; DE AltName: Full=Lemur tyrosine kinase 2; DE AltName: Full=Serine/threonine-protein kinase KPI-2; GN Name=LMTK2; Synonyms=AATYK2, BREK, KIAA1079, KPI2, LMR2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INTERACTION WITH PPP1C RP AND INH2. RC TISSUE=Cervix carcinoma; RX PubMed=12393858; DOI=10.1074/jbc.m209335200; RA Wang H., Brautigan D.L.; RT "A novel transmembrane Ser/Thr kinase complexes with protein phosphatase-1 RT and inhibitor-2."; RL J. Biol. Chem. 277:49605-49612(2002). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT MET-780. RC TISSUE=Brain; RX PubMed=10470851; DOI=10.1093/dnares/6.3.197; RA Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N., Tanaka A., RA Kotani H., Nomura N., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. XIV. The RT complete sequences of 100 new cDNA clones from brain which code for large RT proteins in vitro."; RL DNA Res. 6:197-205(1999). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=12690205; DOI=10.1126/science.1083423; RA Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., RA Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R., RA Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A., RA Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D., RA Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S., RA Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R., RA Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N., RA Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E., RA Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R., RA Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T., RA Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W., RA Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A., RA Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X., RA Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E., RA Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H., RA Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J., RA Adams M.D., Tsui L.-C.; RT "Human chromosome 7: DNA sequence and biology."; RL Science 300:767-772(2003). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=12853948; DOI=10.1038/nature01782; RA Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., RA Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., RA Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., RA Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H., RA Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A., RA Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P., RA Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M., RA Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S., RA Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., RA Strowmatt C., Latreille P., Miller N., Johnson D., Murray J., RA Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., RA Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., RA Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E., RA Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E., RA Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A., RA Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A., RA Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R., RA McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H., RA Wilson R.K.; RT "The DNA sequence of human chromosome 7."; RL Nature 424:157-164(2003). RN [6] RP CHARACTERIZATION. RX PubMed=15005709; DOI=10.1111/j.1356-9597.2004.00714.x; RA Kawa S., Fujimoto J., Tezuka T., Nakazawa T., Yamamoto T.; RT "Involvement of BREK, a serine/threonine kinase enriched in brain, in NGF RT signalling."; RL Genes Cells 9:219-232(2004). RN [7] RP PHOSPHORYLATION. RX PubMed=16887929; DOI=10.1074/mcp.m600188-mcp200; RA Wang H., Brautigan D.L.; RT "Peptide microarray analysis of substrate specificity of the transmembrane RT Ser/Thr kinase KPI-2 reveals reactivity with cystic fibrosis transmembrane RT conductance regulator and phosphorylase."; RL Mol. Cell. Proteomics 5:2124-2130(2006). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Leukemic T-cell; RX PubMed=19690332; DOI=10.1126/scisignal.2000007; RA Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., RA Rodionov V., Han D.K.; RT "Quantitative phosphoproteomic analysis of T cell receptor signaling RT reveals system-wide modulation of protein-protein interactions."; RL Sci. Signal. 2:RA46-RA46(2009). RN [9] RP TOPOLOGY, AND SUBCELLULAR LOCATION. RX PubMed=23114966; DOI=10.1152/ajpcell.00288.2012; RA Nixon A., Jia Y., White C., Bradbury N.A.; RT "Determination of the membrane topology of lemur tyrosine kinase 2 (LMTK2) RT by fluorescence protease protection."; RL Am. J. Physiol. 304:C164-169(2013). RN [10] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-886; SER-1107 AND SER-1450, RP AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [11] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [12] RP VARIANTS [LARGE SCALE ANALYSIS] HIS-484; ILE-595; MET-624; THR-693; RP MET-780; PHE-849; THR-862; ARG-916; ASN-1061; ASN-1220; GLY-1341 AND RP ASN-1401. RX PubMed=17344846; DOI=10.1038/nature05610; RA Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., RA Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., RA Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., RA Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., RA Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., RA Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., RA Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., RA Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., RA Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., RA Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., RA Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., RA Futreal P.A., Stratton M.R.; RT "Patterns of somatic mutation in human cancer genomes."; RL Nature 446:153-158(2007). CC -!- FUNCTION: Phosphorylates PPP1C, phosphorylase b and CFTR. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl- CC [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA- CC COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L- CC threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, CC Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; CC EC=2.7.11.1; CC -!- SUBUNIT: Interacts with PPP1C and inhibitor-2. CC {ECO:0000269|PubMed:12393858}. CC -!- INTERACTION: CC Q8IWU2; P36873: PPP1CC; NbExp=5; IntAct=EBI-2008933, EBI-356283; CC Q8IWU2; P41236: PPP1R2; NbExp=4; IntAct=EBI-2008933, EBI-1056517; CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:23114966}; Multi- CC pass membrane protein {ECO:0000269|PubMed:23114966}. CC -!- TISSUE SPECIFICITY: Mainly expressed in skeletal muscle, and weakly in CC brain and pancreas. {ECO:0000269|PubMed:12393858}. CC -!- PTM: Autophosphorylated. Phosphorylated (By similarity). {ECO:0000250}. CC -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein CC kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}. CC -!- SEQUENCE CAUTION: CC Sequence=BAA83031.2; Type=Erroneous initiation; Evidence={ECO:0000305}; CC -!- WEB RESOURCE: Name=Wikipedia; Note=LMTK2 entry; CC URL="https://en.wikipedia.org/wiki/LMTK2"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY130988; AAN08717.1; -; mRNA. DR EMBL; AB029002; BAA83031.2; ALT_INIT; mRNA. DR EMBL; AC073101; AAS07515.1; -; Genomic_DNA. DR EMBL; CH471091; EAW76721.1; -; Genomic_DNA. DR EMBL; AC091654; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH236956; EAL23894.1; -; Genomic_DNA. DR CCDS; CCDS5654.1; -. DR RefSeq; NP_055731.2; NM_014916.3. DR AlphaFoldDB; Q8IWU2; -. DR SMR; Q8IWU2; -. DR BioGRID; 116524; 102. DR IntAct; Q8IWU2; 82. DR MINT; Q8IWU2; -. DR STRING; 9606.ENSP00000297293; -. DR iPTMnet; Q8IWU2; -. DR PhosphoSitePlus; Q8IWU2; -. DR SwissPalm; Q8IWU2; -. DR BioMuta; LMTK2; -. DR CPTAC; non-CPTAC-6030; -. DR CPTAC; non-CPTAC-6031; -. DR EPD; Q8IWU2; -. DR jPOST; Q8IWU2; -. DR MassIVE; Q8IWU2; -. DR MaxQB; Q8IWU2; -. DR PaxDb; 9606-ENSP00000297293; -. DR PeptideAtlas; Q8IWU2; -. DR ProteomicsDB; 70894; -. DR Pumba; Q8IWU2; -. DR Antibodypedia; 2093; 276 antibodies from 33 providers. DR DNASU; 22853; -. DR Ensembl; ENST00000297293.6; ENSP00000297293.5; ENSG00000164715.6. DR GeneID; 22853; -. DR KEGG; hsa:22853; -. DR MANE-Select; ENST00000297293.6; ENSP00000297293.5; NM_014916.4; NP_055731.2. DR UCSC; uc003upd.3; human. DR AGR; HGNC:17880; -. DR CTD; 22853; -. DR DisGeNET; 22853; -. DR GeneCards; LMTK2; -. DR HGNC; HGNC:17880; LMTK2. DR HPA; ENSG00000164715; Low tissue specificity. DR MIM; 610989; gene. DR neXtProt; NX_Q8IWU2; -. DR OpenTargets; ENSG00000164715; -. DR PharmGKB; PA134884391; -. DR VEuPathDB; HostDB:ENSG00000164715; -. DR eggNOG; ENOG502QSD2; Eukaryota. DR GeneTree; ENSGT00940000158475; -. DR HOGENOM; CLU_004618_0_0_1; -. DR InParanoid; Q8IWU2; -. DR OMA; SHKSVSC; -. DR OrthoDB; 2910608at2759; -. DR PhylomeDB; Q8IWU2; -. DR TreeFam; TF332280; -. DR PathwayCommons; Q8IWU2; -. DR SignaLink; Q8IWU2; -. DR SIGNOR; Q8IWU2; -. DR BioGRID-ORCS; 22853; 9 hits in 1190 CRISPR screens. DR ChiTaRS; LMTK2; human. DR GeneWiki; LMTK2; -. DR GenomeRNAi; 22853; -. DR Pharos; Q8IWU2; Tbio. DR PRO; PR:Q8IWU2; -. DR Proteomes; UP000005640; Chromosome 7. DR RNAct; Q8IWU2; Protein. DR Bgee; ENSG00000164715; Expressed in middle temporal gyrus and 187 other cell types or tissues. DR GO; GO:0005829; C:cytosol; IEA:GOC. DR GO; GO:0005769; C:early endosome; IDA:UniProtKB. DR GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB. DR GO; GO:0030426; C:growth cone; IEA:Ensembl. DR GO; GO:0016020; C:membrane; IDA:UniProtKB. DR GO; GO:0043025; C:neuronal cell body; IEA:Ensembl. DR GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB. DR GO; GO:0055037; C:recycling endosome; IDA:UniProtKB. DR GO; GO:0005524; F:ATP binding; NAS:UniProtKB. DR GO; GO:0070853; F:myosin VI binding; IPI:UniProtKB. DR GO; GO:0004672; F:protein kinase activity; IBA:GO_Central. DR GO; GO:0004864; F:protein phosphatase inhibitor activity; IDA:UniProtKB. DR GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA. DR GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB. DR GO; GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB. DR GO; GO:0032456; P:endocytic recycling; IMP:UniProtKB. DR GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB. DR GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB. DR GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB. DR GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB. DR GO; GO:0001881; P:receptor recycling; IMP:UniProtKB. DR GO; GO:0033572; P:transferrin transport; IMP:UniProtKB. DR CDD; cd05086; PTKc_Aatyk2; 1. DR Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1. DR InterPro; IPR011009; Kinase-like_dom_sf. DR InterPro; IPR000719; Prot_kinase_dom. DR InterPro; IPR017441; Protein_kinase_ATP_BS. DR InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom. DR InterPro; IPR008266; Tyr_kinase_AS. DR PANTHER; PTHR24417; SERINE/THREONINE-PROTEIN KINASE LMTK1; 1. DR PANTHER; PTHR24417:SF8; SERINE_THREONINE-PROTEIN KINASE LMTK2; 1. DR Pfam; PF07714; PK_Tyr_Ser-Thr; 1. DR PRINTS; PR00109; TYRKINASE. DR SUPFAM; SSF56112; Protein kinase-like (PK-like); 1. DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. DR PROSITE; PS00109; PROTEIN_KINASE_TYR; 1. DR Genevisible; Q8IWU2; HS. PE 1: Evidence at protein level; KW ATP-binding; Kinase; Membrane; Nucleotide-binding; Phosphoprotein; KW Reference proteome; Serine/threonine-protein kinase; Transferase; KW Transmembrane; Transmembrane helix. FT CHAIN 1..1503 FT /note="Serine/threonine-protein kinase LMTK2" FT /id="PRO_0000259458" FT TOPO_DOM 1..10 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 11..31 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 32..42 FT /note="Lumenal" FT /evidence="ECO:0000255" FT TRANSMEM 43..63 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 64..1503 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 137..407 FT /note="Protein kinase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT REGION 597..622 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 804..840 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 875..898 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 970..999 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1013..1202 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1276..1317 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1372..1469 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 804..821 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 878..898 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1089..1106 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1183..1202 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1279..1295 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1296..1317 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1427..1469 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 265 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159, FT ECO:0000255|PROSITE-ProRule:PRU10028" FT BINDING 143..151 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT BINDING 168 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT MOD_RES 805 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q3TYD6" FT MOD_RES 806 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q3TYD6" FT MOD_RES 886 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 1107 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 1305 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q3TYD6" FT MOD_RES 1307 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q3TYD6" FT MOD_RES 1308 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q3TYD6" FT MOD_RES 1310 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q3TYD6" FT MOD_RES 1450 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 1496 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q3TYD6" FT MOD_RES 1497 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q3TYD6" FT VARIANT 30 FT /note="P -> A (in dbSNP:rs3735252)" FT /id="VAR_028940" FT VARIANT 484 FT /note="D -> H (in a lung large cell carcinoma sample; FT somatic mutation; dbSNP:rs147940573)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_041727" FT VARIANT 595 FT /note="V -> I (in dbSNP:rs34461195)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_041728" FT VARIANT 624 FT /note="V -> M (in dbSNP:rs34628253)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_041729" FT VARIANT 693 FT /note="I -> T (in dbSNP:rs56204700)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_041730" FT VARIANT 780 FT /note="L -> M (in dbSNP:rs11765552)" FT /evidence="ECO:0000269|PubMed:10470851, FT ECO:0000269|PubMed:17344846" FT /id="VAR_028941" FT VARIANT 849 FT /note="V -> F (in dbSNP:rs56196840)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_041731" FT VARIANT 862 FT /note="A -> T (in dbSNP:rs34005293)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_041732" FT VARIANT 916 FT /note="S -> R (in dbSNP:rs55867257)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_041733" FT VARIANT 1061 FT /note="D -> N (in dbSNP:rs3801295)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_028942" FT VARIANT 1220 FT /note="D -> N (in dbSNP:rs35912712)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_041734" FT VARIANT 1341 FT /note="A -> G (in dbSNP:rs56343792)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_041735" FT VARIANT 1401 FT /note="S -> N (in dbSNP:rs45488394)" FT /evidence="ECO:0000269|PubMed:17344846" FT /id="VAR_041736" FT CONFLICT 910 FT /note="S -> I (in Ref. 1; AAN08717)" FT /evidence="ECO:0000305" FT CONFLICT 1444..1454 FT /note="QTSKYFSPPPP -> PSTLPAFPSHT (in Ref. 2; BAA83031)" FT /evidence="ECO:0000305" FT CONFLICT 1455..1503 FT /note="Missing (in Ref. 2; BAA83031)" FT /evidence="ECO:0000305" SQ SEQUENCE 1503 AA; 164900 MW; 52665B054F04D17A CRC64; MPGPPALRRR LLLLLLVLLI AGSAGAAPLP QTGAGEAPPA AEVSSSFVIL CVCSLIILIV LIANCVSCCK DPEIDFKEFE DNFDDEIDFT PPAEDTPSVQ SPAEVFTLSV PNISLPAPSQ FQPSVEGLKS QVARHSLNYI QEIGNGWFGK VLLGEIYTGT SVARVIVKEL KASANPKEQD TFLKNGEPYY ILQHPNILQC VGQCVEAIPY LLVFEFCDLG DLKAYLRSEQ EHMRGDSQTM LLQRMACEVA AGLAAMHKLH FLHSDLALRN CFLTSDLNVK VGDYGIGFSR YKEDYIETDD KKVFPLRWTA PELVTSFQDR LLTADQTKYS NIWSLGVTLW ELFDNAAQPY SNLSNLDVLN QVIRERDTKL PKPQLEQPYS DRWYEVLQFC WLSPEKRPAA EDVHRLLTYL RLQSQRDSEV DFEQQWNALK PNTNSRDSSN NAAFPILDHF ARDRLGREME EVLTVTETSQ GLSFEYVWEA AKHDHFDERS RGHLDEGLSY TSIFYPVEVF ESSLSDPGPG KQDDSGQDVP LRVPGVVPVF DAHNLSVGSD YYIQLEEKSG SNLELDYPPA LLTTDMDNPE RTGPELSQLT ALRSVELEES STDEDFFQSS TDPKDSSLPG DLHVTSGPES PFNNIFNDVD KSEDLPSHQK IFDLMELNGV QADFKPATLS SSLDNPKESV ITGHFEKEKP RKIFDSEPLC LSDNLMHQDN FDPLNVQELS ENFLFLQEKN LLKGSLSSKE HINDLQTELK NAGFTEAMLE TSCRNSLDTE LQFAENKPGL SLLQENVSTK GDDTDVMLTG DTLSTSLQSS PEVQVPPTSF ETEETPRRVP PDSLPTQGET QPTCLDVIVP EDCLHQDISP DAVTVPVEIL STDARTHSLD NRSQDSPGES EETLRLTESD SVLADDILAS RVSVGSSLPE LGQELHNKPF SEDHHSHRRL EKNLEAVETL NQLNSKDAAK EAGLVSALSS DSTSQDSLLE DSLSAPFPAS EPSLETPDSL ESVDVHEALL DSLGSHTPQK LVPPDKPADS GYETENLESP EWTLHPAPEG TADSEPATTG DGGHSGLPPN PVIVISDAGD GHRGTEVTPE TFTAGSQGSY RDSAYFSDND SEPEKRSEEV PGTSPSALVL VQEQPLPEPV LPEQSPAAQD SCLEARKSQP DESCLSALHN SSDLELRATP EPAQTGVPQQ VHPTEDEASS PWSVLNAELS SGDDFETQDD RPCTLASTGT NTNELLAYTN SALDKSLSSH SEGPKLKEPD IEGKYLGKLG VSGMLDLSED GMDADEEDEN SDDSDEDLRA FNLHSLSSES EDETEHPVPI ILSNEDGRHL RSLLKPTAAN APDPLPEDWK KEKKAVTFFD DVTVYLFDQE TPTKELGPCG GEACGPDLSG PAPASGSPYL SRCINSESST DEEGGGFEWD DDFSPDPFMS KTTSNLLSSK PSLQTSKYFS PPPPARSTEQ SWPHSAPYSR FSISPANIAS FSLTHLTDSD IEQGGSSEDG EKD //